Dialog
Dialog Support   >   "How Do I...?" Series   >   Patents
Dialog "How Do I...?" - Patents

Find Information on New Technologies and Pending Patents?

TOPIC: Information on pending U.S. patents may be obtained in the patent databases only if the application has published internationally or in the U.S. as a Pre-grant publication.

Using Dialog NewsRoom (File 990), a comprehensive, global news source that covers the leading newspapers, business magazines and newswires from all regions of the world, and Gale Group Newsletter Database (File 636), which contains the fulltext of specialty industry newsletters, you will be able to find additional, late-breaking information on pending patents for new technologies, as well as the background on the companies pursuing the patents.

 

COMMAND SUMMARY

BEGIN 636,990 CURRENT2
SELECT PATENT?(1N)(PENDING? OR APPLIC?)
SELECT S1 AND PROVECTUS/CO
REMOVE DUPLICATES
TYPE S3/8/1-3 FROM EACH
TYPE S3/7/16


HOW TO...



1. BEGIN Files 636 and 990 to search two key business databases together. Use the CURRENT2 feature to restrict the search to this year plus two years back.

2. SELECT terms for the first concept. Use the proximity connector (1N) for words adjacent, within one intervening word, in any order. OR synonyms together and enclose in parentheses.

3. Combine Set 1 (S1) with the name of the company in which you are interested on the Company Name field (/CO).

4. REMOVE DUPLICATES (RD) when searching more than one database.

?B636,990 CURRENT2

SYSTEM:OS  - DIALOG OneSearch
  File 636:Gale Group Newsletter DB(TM) 1987-2007/Nov 29
         (c) 2007 The Gale Group
  File 990:NewsRoom Current Jul 01-2007/Dec 04
         (c) 2007 Dialog
>>>CURRENT2 started

      Set  Items  Description
      ---  -----  -----------
?S PATENT?(1N)(PENDING? OR APPLIC?)
          193945  PATENT?
          155582  PENDING?
          813385  APPLIC?
      S1   30511  PATENT?(1N)(PENDING? OR APPLIC?)

?S   S1 AND PROVECTUS/CO
           30511  S1
             212  PROVECTUS/CO
      S2      58  S1 AND PROVECTUS/CO

?RD
      S3      36  RD  (unique items)


5. TYPE a sampling of titles FROM EACH of the databases using Format 8,K, which gives titles, publication dates and descriptors, and Key Word in Context (KWIC [K]).

To select the appropriate record number, look at the range of records in the TYPE command (e.g., 3/8,K/16 (Item 2 from File 990)).

Note: Some records have been omitted from this display.

?T S3/8,K/1-2 FROM EACH 
        
        3/8,K/1  (Item 1 from file: 636) 
        DIALOG(R)File  636: Gale Group Newsletter DB(TM)
        (c)  2007 The Gale Group. All rights reserved.

06665118   Supplier Number: 169988863 (USE FORMAT 7 FOR 
        FULLTEXT)

Speak  with other shareholders about: (OTC BB:PVCT) , 
        (Nasdaq:CACH) , (OTC BB:SKNY) ,  (NYSE:BSX).  
        Oct 18 , 2007 
        Word  Count: 2147 
        Publisher  Name: M2  Communications Ltd. 
        Company Names: *Provectus Pharmaceuticals Inc. 
        Industry  Names: BUSN  (Business); INTL (Business, 
        international) 

...Pharmaceuticals, Inc. (OTCBB: PVCT - News) announced today 
it has received allowance of its U.S. patent   application, 
protecting diagnostic uses of a new class of radiochemical . . .
(....)

  3/8,K/15  (Item 1 from file: 990) 
        DIALOG(R)File  990: NewsRoom Current
        (c)  2007 Dialog. All rights reserved.

  1491518394    17V70KYT 
    StockDiagnostics.com  Reiterates Provectus  
Pharmaceutical's  OPS Ranking of "8" 

Market  News Publishing US 
       Tuesday , November 20, 2007 
        Word  Count: 397

Company  Names: ZAMAGE  DIGITAL IMAGING INC; SPM GROUP 
   INC; PROVECTUS PHARMACEUTICAL INC; PROVECTUS 
   PHARMACEUTICALS INC; EPS  BIO TECHNOLOGY CORP; OPS 
Dialog  Update Date: 20071120;  00:31:05 EST 
   
  Text: 

...of public companies. Go to stockdiagnostics@baystreet.com for a 
description of StockDiagnostics.com's patent-pending  technical 
applications, such as OPS, OPS Rankings, The EPS Syndrome and 
more. Full details are...

  3/8,K/16 (Item 2 from file: 990) 
        DIALOG(R)File  990: NewsRoom Current
        (c)  2007 Dialog. All rights reserved.

  1490004723    17V404ML 
          Provectus Receives Patent Allowance  From U.S.  
Patent Office

Obesity,  Fitness & Wellness Week 
        Saturday , November 17, 2007 
        Word  Count: 216

Company  Names: ZAMAGE  DIGITAL IMAGING INC; SPM GROUP INC; 
PROVECTUS PHARMACEUTICAL INC; PROVECTUS PHARMACEUTICALS INC 
Dialog  Update Date: 20071109;  20:40:51 EST 
Event  Names: PATENTS  AND TRADEMARKS; ECONOMIC DEVELOPMENT 
Geographic  Names: USA; AMERICAS;  NORTH AMERICA 
Industry  Names: HEALTH  CARE SERVICES; MEDICAL AND HEALTH 
Journal  Subject: Health  & Wellness; Healthcare

Text:
      ...Pharmaceuticals, Inc. (OTCBB: PVCT, http://www.pvct.com) 
        has received allowance of its U.S.  patent application, 
        protecting therapeutic agents based on a novel radio dense 
        analog of its lead therapeutic product PV-10, from the United 
        States Patent and Trademark Office (USPTO) (see also).

The pending patent covers therapeutic agents that are....


6. TYPE selected records in Format 7, which gives the Bibliographic Citation and the Text.

The TYPE command in the example requests record number 16, which is the second record from File 990. The searcher may also use the FROM command and the database number to select a record from a particular database. For example, the TYPE command could have read T S3/7/2 FROM 990 to display the same record.

Note: Part of this record is omitted from the display


?t s3/7/16 

  3/7/16 (Item 2 from file: 990) 
        DIALOG(R)File  990: NewsRoom Current
        (c)  2007 Dialog. All rights reserved.
  1490004723    17V404ML 
  Provectus  Receives Patent Allowance From U.S.  Patent Office 
Obesity,  Fitness & Wellness Week , p 4192 
        Saturday , November 17, 2007 
        Word  Count: 216 

Text:
   Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, http://www.pvct.com) 
    has received allowance of its U.S. patent application, protecting 
    therapeutic agents based on a novel radio dense analog of its lead 
    therapeutic product PV-10, from the United States Patent and Trademark 
    Office (USPTO) (see also).

The pending patent covers therapeutic agents that are used in 
conjunction with radiation therapy to improve the efficiency and
specificity of radiation for oncology. The agents, called radio 
sensitizers, are based on a novel molecule related to PV-10, the 
Company's lead oncology product. "Like PV-10, these new agents are 
not radioactive; instead....”

Dees continued: "We remain focused on the therapeutic uses of PV-10 
as a stand-alone product category, but cannot ignore the large potential 
value of these products for cancer markets worldwide....”

Copyright (c) 2007 Obesity, Fitness & Wellness Week via NewsRx.com

RELATED HOW DO I...? SOLUTIONS

 

NEED HELP?

Contact the Dialog Knowledge Center
Within North America +1 800 3 DIALOG (334 2564)
Outside North America 00 800 33 DIALOG (33 34 2564)
Web Form www.dialog.com/contacts/webform

Stock #: 54157; Last modified: 14 Sep 2011



You are viewing the
Dialog Classic Version

Click below to view the
DialogLink 5 Version
Dialog Home   |   About Dialog   |   Site Search
Copyright Notices   |   Terms of Use   |   Privacy Statement